RxSight Inc
RXST
Get informed when a big investor buys or sells
+ FollowMarket Cap$199.12M
Close$
Share Statistics
| Market cap | $199.12 Million |
|---|---|
| Enterprise Value | $203.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.95 |
| Beta | 1.14 |
| Outstanding Shares | 41,490,889 |
Return
| Return on Equity | -17.83% |
|---|---|
| Return on Assets | -13.31% |
| Return on Invested Capital | -18.79% |
Valuation & Multiples
| P/E Ratio | -4.26 |
|---|---|
| PEG | -161.31 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 0.75 |
| Enterprise Value to Revenue | 1.59 |
| Enterprise Value to EBIT | -3.97 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$32.07 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$27.19 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 100.61% |
|---|---|
| Total Invested | $22,128▼ 99.99% |
| Investors Holding | 4▼ 150.00% |
ESG Score
No data
About RxSight Inc
2,021 employees